GTX Regimen for Biliary Cancers

NCT00868998 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Poor patient accrual

Conditions

Biliary Cancer

Interventions

DRUG: Gemcitabine, docetaxel, and capecitabine

Sponsor

Columbia University